Bausch Health Companies Inc. (NYSE/TSX: BHC) has announced the resignation of Chief Financial Officer Tom Vadaketh. Vadaketh has chosen to pursue another opportunity and will officially depart from the Company on October 13, 2023. The Company expresses its appreciation to Mr. Vadaketh for his significant contributions and leadership during a period of transition.
The Company has initiated a formal search process to identify a permanent replacement for Mr. Vadaketh. In case a permanent replacement is not secured by the time of Mr. Vadaketh’s departure, the Company plans to appoint John S. Barresi, who currently holds the position of Senior Vice President, Controller, and Chief Accounting Officer, as interim Chief Financial Officer. Mr. Barresi boasts over 15 years of experience as a corporate finance executive.
Bausch Health is a globally diversified pharmaceutical company with a mission to enhance people’s lives through its healthcare products. With its leading durable brands, the company is committed to advancing global health while fulfilling its commitments as an innovative healthcare company.
Have you read?
The world’s largest economies in 2023.
Ranked: Safest Countries in the World, 2023.
Countries With the Most Female Billionaires, 2023.
Economy Rankings: Largest countries by GDP, 2023.
The Global Passport Index: The World’s Most Powerful Passports.
Add CEOWORLD magazine to your Google News feed.
Follow CEOWORLD magazine headlines on: Google News, LinkedIn, Twitter, and Facebook.
Copyright 2024 The CEOWORLD magazine. All rights reserved. This material (and any extract from it) must not be copied, redistributed or placed on any website, without CEOWORLD magazine' prior written consent. For media queries, please contact: info@ceoworld.biz
